Reference
Chatzellis E, et al. Activity and Safety of Standard and Prolonged Capecitabine/Temozolomide Administration in Patients with Advanced Neuroendocrine Neoplasms. Neuroendocrinology 109: 333-345, No. 4, Nov 2019. Available from: URL: http://doi.org/10.1159/000500135
Rights and permissions
About this article
Cite this article
Aspirin/capecitabine/temozolomide. Reactions Weekly 1810, 45 (2020). https://doi.org/10.1007/s40278-020-80065-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-80065-2